Inhalational anesthetics as preconditioning agents in ischemic brain

Area of Science:

• Neuroscience
• Pharmacology
• Anesthesiology

Background:

• Cerebral ischemia poses a significant clinical challenge, with limited success of pharmacological neuroprotection in humans.
• Preconditioning, a strategy to increase brain tolerance to ischemia, presents a potential therapeutic avenue.
• Various methods exist to induce preconditioning, including ischemia, pharmacological agents, hypoxia, and endotoxin.

Purpose of the Study:

• To explore the potential of preconditioning as a neuroprotective strategy in humans.
• To investigate the role of inhalational anesthetic agents in inducing brain preconditioning.
• To understand the mechanisms underlying brain preconditioning and the unique contribution of anesthetics.

Main Methods:

• Review of existing literature on neuroprotection and preconditioning strategies.
• Analysis of studies investigating anesthetic-induced brain preconditioning.
• Exploration of proposed molecular mechanisms involved in preconditioning.

Main Results:

• Pharmacological agents have shown limited success in clinical translation for cerebral ischemia.
• Preconditioning, including that induced by inhalational anesthetics, is a viable strategy to enhance ischemic tolerance.
• Mechanisms involve pathways like Akt activation, ATP-sensitive potassium channels, and nitric oxide, though complex and not fully elucidated.

Conclusions:

• Preconditioning represents a promising clinical neuroprotective approach for cerebral ischemia.
• Inhalational anesthetics may play a significant and distinct role in perioperative brain preconditioning.
• Further research into anesthetic-mediated preconditioning mechanisms is warranted for clinical application.